The phrase "assess binding to" is correct and usable in written English.
It can be used in contexts related to evaluating the interaction or attachment of molecules, such as in biochemistry or pharmacology.
Example: "In our study, we aim to assess binding to the target protein to determine the efficacy of the new drug."
Alternatives: "evaluate attachment to" or "analyze binding with".
To assess binding to the native conformation, conditions that readily denature myosin, e.g. dilute protein concentrations at elevated temperatures, were avoided.
However, we wished to assess binding to combinations of sphingolipids and gangliosides in a more membrane-like setting that would support microdomain formation.
Accordingly we employed recombinant BSP, BSP purified from bone, or recombinant human BSP to assess binding to proMMP-2.
Radioligand binding assays were contracted to CEREP (Celle l'Evescault, France) where membranes from CHO-cells expressing either hCB1R or hCB2R were used to assess binding to the two cannabinoid receptors.
To address if QIL1 also interacted with MIC10, we immunopurified endogenous MIC10 in isolated mitochondria from 293T cells and assessed binding to QIL1 by western blot analysis.
A direct interaction was next explored by assessing binding to the ENTH domain of epsin 1 (with an His tag at the C-terminus) to increasing concentrations of the cytosolic portion of Syb2 fused to GST.
To test this hypothesis, we performed ChIP to assess binding of ESE3 to the promoters in parental and ERG-expressing LNCaP cells.
To test this hypothesis, we performed ChIP to assess binding of ESE3 to the regions of the EZH2 and Nkx3.1 promoters containing the identified EBS in parental and ESE3-kd LNCaP cells.
Finally, to prove that this interaction occurred also in clinical tumor specimens we performed ChIP to assess binding of ERG to the EZH2 promoter in ERGhigh and NoETS samples (Fig. 3G).
Although the Initiative emphasises the role of imaging in assessment of biomarkers, medical imaging also has other applications in drug discovery: "a molecular imaging probe can be used to determine target occupancy before and after administration of a new drug candidate, which helps to assess binding affinity and to determine correct dosages" [13].
